nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—Hepatic insufficiency—Methotrexate—urinary bladder cancer	0.02	0.0366	CcSEcCtD
Diclofenamide—CA14—prostate gland—urinary bladder cancer	0.0194	0.0742	CbGeAlD
Diclofenamide—CA5A—female reproductive system—urinary bladder cancer	0.0191	0.0731	CbGeAlD
Diclofenamide—CYP2C9—urine—urinary bladder cancer	0.0183	0.07	CbGeAlD
Diclofenamide—CA14—seminal vesicle—urinary bladder cancer	0.0164	0.0627	CbGeAlD
Diclofenamide—CA7—renal system—urinary bladder cancer	0.0159	0.0607	CbGeAlD
Diclofenamide—CA5B—prostate gland—urinary bladder cancer	0.0136	0.0519	CbGeAlD
Diclofenamide—Metabolic acidosis—Etoposide—urinary bladder cancer	0.013	0.0239	CcSEcCtD
Diclofenamide—Pollakiuria—Valrubicin—urinary bladder cancer	0.012	0.022	CcSEcCtD
Diclofenamide—CA9—female reproductive system—urinary bladder cancer	0.0112	0.0427	CbGeAlD
Diclofenamide—CA12—renal system—urinary bladder cancer	0.0103	0.0394	CbGeAlD
Diclofenamide—Eruption—Gemcitabine—urinary bladder cancer	0.00982	0.018	CcSEcCtD
Diclofenamide—CA4—prostate gland—urinary bladder cancer	0.00936	0.0358	CbGeAlD
Diclofenamide—CA5B—urethra—urinary bladder cancer	0.00908	0.0347	CbGeAlD
Diclofenamide—CA12—female reproductive system—urinary bladder cancer	0.00826	0.0316	CbGeAlD
Diclofenamide—CA1—renal system—urinary bladder cancer	0.00817	0.0312	CbGeAlD
Diclofenamide—Drowsiness—Mitomycin—urinary bladder cancer	0.00799	0.0147	CcSEcCtD
Diclofenamide—CA4—seminal vesicle—urinary bladder cancer	0.00792	0.0303	CbGeAlD
Diclofenamide—CA2—prostate gland—urinary bladder cancer	0.00776	0.0297	CbGeAlD
Diclofenamide—Hyperuricaemia—Thiotepa—urinary bladder cancer	0.00774	0.0142	CcSEcCtD
Diclofenamide—CA5B—female reproductive system—urinary bladder cancer	0.00741	0.0283	CbGeAlD
Diclofenamide—Blood uric acid increased—Thiotepa—urinary bladder cancer	0.00731	0.0134	CcSEcCtD
Diclofenamide—CA5B—vagina—urinary bladder cancer	0.0067	0.0256	CbGeAlD
Diclofenamide—CA2—seminal vesicle—urinary bladder cancer	0.00657	0.0251	CbGeAlD
Diclofenamide—CA1—female reproductive system—urinary bladder cancer	0.00654	0.025	CbGeAlD
Diclofenamide—CA4—renal system—urinary bladder cancer	0.00638	0.0244	CbGeAlD
Diclofenamide—CA4—urethra—urinary bladder cancer	0.00627	0.024	CbGeAlD
Diclofenamide—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00609	0.0112	CcSEcCtD
Diclofenamide—Hyperuricaemia—Cisplatin—urinary bladder cancer	0.00607	0.0111	CcSEcCtD
Diclofenamide—Body temperature increased—Valrubicin—urinary bladder cancer	0.00585	0.0107	CcSEcCtD
Diclofenamide—Hepatic failure—Thiotepa—urinary bladder cancer	0.0058	0.0106	CcSEcCtD
Diclofenamide—Blood uric acid increased—Cisplatin—urinary bladder cancer	0.00573	0.0105	CcSEcCtD
Diclofenamide—CA2—epithelium—urinary bladder cancer	0.00571	0.0218	CbGeAlD
Diclofenamide—Leukopenia—Mitomycin—urinary bladder cancer	0.00559	0.0103	CcSEcCtD
Diclofenamide—Hyperuricaemia—Etoposide—urinary bladder cancer	0.00556	0.0102	CcSEcCtD
Diclofenamide—CA2—smooth muscle tissue—urinary bladder cancer	0.0055	0.021	CbGeAlD
Diclofenamide—Body temperature increased—Carboplatin—urinary bladder cancer	0.00541	0.00993	CcSEcCtD
Diclofenamide—Asthenia—Valrubicin—urinary bladder cancer	0.00531	0.00974	CcSEcCtD
Diclofenamide—CA2—renal system—urinary bladder cancer	0.00529	0.0202	CbGeAlD
Diclofenamide—Blood uric acid increased—Etoposide—urinary bladder cancer	0.00525	0.00964	CcSEcCtD
Diclofenamide—Pruritus—Valrubicin—urinary bladder cancer	0.00523	0.0096	CcSEcCtD
Diclofenamide—Confusional state—Mitomycin—urinary bladder cancer	0.00514	0.00943	CcSEcCtD
Diclofenamide—CA4—female reproductive system—urinary bladder cancer	0.00511	0.0196	CbGeAlD
Diclofenamide—Eruption—Methotrexate—urinary bladder cancer	0.00502	0.00922	CcSEcCtD
Diclofenamide—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00499	0.00915	CcSEcCtD
Diclofenamide—Ataxia—Thiotepa—urinary bladder cancer	0.0049	0.00899	CcSEcCtD
Diclofenamide—Dizziness—Valrubicin—urinary bladder cancer	0.00489	0.00897	CcSEcCtD
Diclofenamide—Hepatic failure—Gemcitabine—urinary bladder cancer	0.00488	0.00895	CcSEcCtD
Diclofenamide—Anorexia—Mitomycin—urinary bladder cancer	0.00486	0.00891	CcSEcCtD
Diclofenamide—Disorientation—Fluorouracil—urinary bladder cancer	0.00482	0.00884	CcSEcCtD
Diclofenamide—Vomiting—Valrubicin—urinary bladder cancer	0.0047	0.00863	CcSEcCtD
Diclofenamide—Eruption—Epirubicin—urinary bladder cancer	0.0047	0.00863	CcSEcCtD
Diclofenamide—Rash—Valrubicin—urinary bladder cancer	0.00466	0.00856	CcSEcCtD
Diclofenamide—Headache—Valrubicin—urinary bladder cancer	0.00463	0.0085	CcSEcCtD
Diclofenamide—Somnolence—Mitomycin—urinary bladder cancer	0.00453	0.00831	CcSEcCtD
Diclofenamide—Decreased appetite—Mitomycin—urinary bladder cancer	0.00443	0.00813	CcSEcCtD
Diclofenamide—Nausea—Valrubicin—urinary bladder cancer	0.00439	0.00806	CcSEcCtD
Diclofenamide—Fatigue—Mitomycin—urinary bladder cancer	0.00439	0.00806	CcSEcCtD
Diclofenamide—Eruption—Doxorubicin—urinary bladder cancer	0.00435	0.00798	CcSEcCtD
Diclofenamide—CA5B—lymph node—urinary bladder cancer	0.00433	0.0166	CbGeAlD
Diclofenamide—CA2—female reproductive system—urinary bladder cancer	0.00424	0.0162	CbGeAlD
Diclofenamide—Feeling abnormal—Mitomycin—urinary bladder cancer	0.0042	0.0077	CcSEcCtD
Diclofenamide—Ataxia—Fluorouracil—urinary bladder cancer	0.00405	0.00744	CcSEcCtD
Diclofenamide—Body temperature increased—Mitomycin—urinary bladder cancer	0.00403	0.00739	CcSEcCtD
Diclofenamide—Hypokalaemia—Gemcitabine—urinary bladder cancer	0.00399	0.00732	CcSEcCtD
Diclofenamide—CA2—vagina—urinary bladder cancer	0.00383	0.0147	CbGeAlD
Diclofenamide—CA1—lymph node—urinary bladder cancer	0.00383	0.0146	CbGeAlD
Diclofenamide—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00375	0.00688	CcSEcCtD
Diclofenamide—Hypokalaemia—Cisplatin—urinary bladder cancer	0.00372	0.00683	CcSEcCtD
Diclofenamide—Asthenia—Mitomycin—urinary bladder cancer	0.00366	0.00671	CcSEcCtD
Diclofenamide—CYP2C9—female reproductive system—urinary bladder cancer	0.00359	0.0137	CbGeAlD
Diclofenamide—Dizziness—Mitomycin—urinary bladder cancer	0.00337	0.00618	CcSEcCtD
Diclofenamide—Tinnitus—Thiotepa—urinary bladder cancer	0.00336	0.00617	CcSEcCtD
Diclofenamide—Hyperuricaemia—Methotrexate—urinary bladder cancer	0.00333	0.00611	CcSEcCtD
Diclofenamide—Vomiting—Mitomycin—urinary bladder cancer	0.00324	0.00594	CcSEcCtD
Diclofenamide—Rash—Mitomycin—urinary bladder cancer	0.00321	0.00589	CcSEcCtD
Diclofenamide—Headache—Mitomycin—urinary bladder cancer	0.00319	0.00586	CcSEcCtD
Diclofenamide—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00315	0.00579	CcSEcCtD
Diclofenamide—Blood uric acid increased—Methotrexate—urinary bladder cancer	0.00315	0.00577	CcSEcCtD
Diclofenamide—Hyperuricaemia—Epirubicin—urinary bladder cancer	0.00312	0.00572	CcSEcCtD
Diclofenamide—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.0031	0.00569	CcSEcCtD
Diclofenamide—Tension—Thiotepa—urinary bladder cancer	0.00308	0.00565	CcSEcCtD
Diclofenamide—Nervousness—Thiotepa—urinary bladder cancer	0.00305	0.00559	CcSEcCtD
Diclofenamide—Nausea—Mitomycin—urinary bladder cancer	0.00303	0.00555	CcSEcCtD
Diclofenamide—CA4—lymph node—urinary bladder cancer	0.00299	0.0114	CbGeAlD
Diclofenamide—Blood uric acid increased—Epirubicin—urinary bladder cancer	0.00294	0.0054	CcSEcCtD
Diclofenamide—Hyperuricaemia—Doxorubicin—urinary bladder cancer	0.00288	0.00529	CcSEcCtD
Diclofenamide—Leukopenia—Thiotepa—urinary bladder cancer	0.00281	0.00516	CcSEcCtD
Diclofenamide—Blood uric acid increased—Doxorubicin—urinary bladder cancer	0.00272	0.005	CcSEcCtD
Diclofenamide—Agranulocytosis—Etoposide—urinary bladder cancer	0.00269	0.00494	CcSEcCtD
Diclofenamide—Tinnitus—Cisplatin—urinary bladder cancer	0.00264	0.00484	CcSEcCtD
Diclofenamide—Confusional state—Thiotepa—urinary bladder cancer	0.00258	0.00474	CcSEcCtD
Diclofenamide—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00251	0.0046	CcSEcCtD
Diclofenamide—Hepatic failure—Methotrexate—urinary bladder cancer	0.0025	0.00458	CcSEcCtD
Diclofenamide—CA2—lymph node—urinary bladder cancer	0.00248	0.00948	CbGeAlD
Diclofenamide—Anorexia—Thiotepa—urinary bladder cancer	0.00244	0.00448	CcSEcCtD
Diclofenamide—Leukopenia—Gemcitabine—urinary bladder cancer	0.00236	0.00434	CcSEcCtD
Diclofenamide—Hepatic failure—Epirubicin—urinary bladder cancer	0.00234	0.00429	CcSEcCtD
Diclofenamide—Leukopenia—Fluorouracil—urinary bladder cancer	0.00232	0.00426	CcSEcCtD
Diclofenamide—Tremor—Cisplatin—urinary bladder cancer	0.00231	0.00423	CcSEcCtD
Diclofenamide—Paraesthesia—Thiotepa—urinary bladder cancer	0.0023	0.00422	CcSEcCtD
Diclofenamide—Somnolence—Thiotepa—urinary bladder cancer	0.00228	0.00418	CcSEcCtD
Diclofenamide—Dyspepsia—Thiotepa—urinary bladder cancer	0.00226	0.00414	CcSEcCtD
Diclofenamide—Decreased appetite—Thiotepa—urinary bladder cancer	0.00223	0.00409	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00221	0.00406	CcSEcCtD
Diclofenamide—Fatigue—Thiotepa—urinary bladder cancer	0.00221	0.00405	CcSEcCtD
Diclofenamide—Leukopenia—Cisplatin—urinary bladder cancer	0.0022	0.00404	CcSEcCtD
Diclofenamide—Constipation—Thiotepa—urinary bladder cancer	0.00219	0.00402	CcSEcCtD
Diclofenamide—Hepatic failure—Doxorubicin—urinary bladder cancer	0.00216	0.00397	CcSEcCtD
Diclofenamide—Confusional state—Fluorouracil—urinary bladder cancer	0.00214	0.00392	CcSEcCtD
Diclofenamide—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00211	0.00387	CcSEcCtD
Diclofenamide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00211	0.00387	CcSEcCtD
Diclofenamide—Ataxia—Methotrexate—urinary bladder cancer	0.00211	0.00387	CcSEcCtD
Diclofenamide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00207	0.00381	CcSEcCtD
Diclofenamide—Anorexia—Gemcitabine—urinary bladder cancer	0.00205	0.00377	CcSEcCtD
Diclofenamide—Body temperature increased—Thiotepa—urinary bladder cancer	0.00203	0.00372	CcSEcCtD
Diclofenamide—Anorexia—Fluorouracil—urinary bladder cancer	0.00202	0.00371	CcSEcCtD
Diclofenamide—Leukopenia—Etoposide—urinary bladder cancer	0.00202	0.0037	CcSEcCtD
Diclofenamide—Ataxia—Epirubicin—urinary bladder cancer	0.00197	0.00362	CcSEcCtD
Diclofenamide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00197	0.00361	CcSEcCtD
Diclofenamide—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00194	0.00355	CcSEcCtD
Diclofenamide—Somnolence—Gemcitabine—urinary bladder cancer	0.00192	0.00352	CcSEcCtD
Diclofenamide—Anorexia—Cisplatin—urinary bladder cancer	0.00191	0.00351	CcSEcCtD
Diclofenamide—Hypokalaemia—Epirubicin—urinary bladder cancer	0.00191	0.0035	CcSEcCtD
Diclofenamide—Paraesthesia—Fluorouracil—urinary bladder cancer	0.0019	0.00349	CcSEcCtD
Diclofenamide—Somnolence—Fluorouracil—urinary bladder cancer	0.00188	0.00346	CcSEcCtD
Diclofenamide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00187	0.00344	CcSEcCtD
Diclofenamide—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00187	0.00342	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00186	0.00341	CcSEcCtD
Diclofenamide—Fatigue—Gemcitabine—urinary bladder cancer	0.00186	0.00341	CcSEcCtD
Diclofenamide—Confusional state—Etoposide—urinary bladder cancer	0.00186	0.0034	CcSEcCtD
Diclofenamide—Constipation—Gemcitabine—urinary bladder cancer	0.00184	0.00338	CcSEcCtD
Diclofenamide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00184	0.00338	CcSEcCtD
Diclofenamide—Asthenia—Thiotepa—urinary bladder cancer	0.00184	0.00337	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00183	0.00336	CcSEcCtD
Diclofenamide—Ataxia—Doxorubicin—urinary bladder cancer	0.00183	0.00335	CcSEcCtD
Diclofenamide—Pruritus—Thiotepa—urinary bladder cancer	0.00181	0.00333	CcSEcCtD
Diclofenamide—Paraesthesia—Cisplatin—urinary bladder cancer	0.0018	0.00331	CcSEcCtD
Diclofenamide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.0018	0.00331	CcSEcCtD
Diclofenamide—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00178	0.00326	CcSEcCtD
Diclofenamide—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.00177	0.00324	CcSEcCtD
Diclofenamide—Anorexia—Etoposide—urinary bladder cancer	0.00175	0.00322	CcSEcCtD
Diclofenamide—Decreased appetite—Cisplatin—urinary bladder cancer	0.00175	0.0032	CcSEcCtD
Diclofenamide—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00175	0.0032	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00173	0.00318	CcSEcCtD
Diclofenamide—Drowsiness—Methotrexate—urinary bladder cancer	0.00173	0.00317	CcSEcCtD
Diclofenamide—Body temperature increased—Gemcitabine—urinary bladder cancer	0.0017	0.00313	CcSEcCtD
Diclofenamide—Dizziness—Thiotepa—urinary bladder cancer	0.00169	0.00311	CcSEcCtD
Diclofenamide—Pollakiuria—Epirubicin—urinary bladder cancer	0.00168	0.00307	CcSEcCtD
Diclofenamide—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00168	0.00307	CcSEcCtD
Diclofenamide—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00166	0.00304	CcSEcCtD
Diclofenamide—Paraesthesia—Etoposide—urinary bladder cancer	0.00165	0.00303	CcSEcCtD
Diclofenamide—Weight decreased—Epirubicin—urinary bladder cancer	0.00164	0.00301	CcSEcCtD
Diclofenamide—Somnolence—Etoposide—urinary bladder cancer	0.00164	0.003	CcSEcCtD
Diclofenamide—Vomiting—Thiotepa—urinary bladder cancer	0.00163	0.00299	CcSEcCtD
Diclofenamide—Drowsiness—Epirubicin—urinary bladder cancer	0.00162	0.00297	CcSEcCtD
Diclofenamide—Rash—Thiotepa—urinary bladder cancer	0.00162	0.00296	CcSEcCtD
Diclofenamide—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00161	0.00296	CcSEcCtD
Diclofenamide—Headache—Thiotepa—urinary bladder cancer	0.00161	0.00294	CcSEcCtD
Diclofenamide—Decreased appetite—Etoposide—urinary bladder cancer	0.0016	0.00294	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00159	0.00292	CcSEcCtD
Diclofenamide—Body temperature increased—Cisplatin—urinary bladder cancer	0.00159	0.00291	CcSEcCtD
Diclofenamide—Fatigue—Etoposide—urinary bladder cancer	0.00159	0.00291	CcSEcCtD
Diclofenamide—Constipation—Etoposide—urinary bladder cancer	0.00157	0.00289	CcSEcCtD
Diclofenamide—Pollakiuria—Doxorubicin—urinary bladder cancer	0.00155	0.00285	CcSEcCtD
Diclofenamide—Asthenia—Gemcitabine—urinary bladder cancer	0.00155	0.00284	CcSEcCtD
Diclofenamide—Pruritus—Gemcitabine—urinary bladder cancer	0.00152	0.0028	CcSEcCtD
Diclofenamide—Nausea—Thiotepa—urinary bladder cancer	0.00152	0.00279	CcSEcCtD
Diclofenamide—Weight decreased—Doxorubicin—urinary bladder cancer	0.00152	0.00279	CcSEcCtD
Diclofenamide—Feeling abnormal—Etoposide—urinary bladder cancer	0.00152	0.00278	CcSEcCtD
Diclofenamide—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00151	0.00277	CcSEcCtD
Diclofenamide—Pruritus—Fluorouracil—urinary bladder cancer	0.0015	0.00275	CcSEcCtD
Diclofenamide—Drowsiness—Doxorubicin—urinary bladder cancer	0.0015	0.00275	CcSEcCtD
Diclofenamide—Body temperature increased—Etoposide—urinary bladder cancer	0.00145	0.00267	CcSEcCtD
Diclofenamide—Tinnitus—Methotrexate—urinary bladder cancer	0.00145	0.00265	CcSEcCtD
Diclofenamide—Asthenia—Cisplatin—urinary bladder cancer	0.00144	0.00264	CcSEcCtD
Diclofenamide—Dizziness—Fluorouracil—urinary bladder cancer	0.0014	0.00257	CcSEcCtD
Diclofenamide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.0014	0.00256	CcSEcCtD
Diclofenamide—Vomiting—Gemcitabine—urinary bladder cancer	0.00137	0.00251	CcSEcCtD
Diclofenamide—Rash—Gemcitabine—urinary bladder cancer	0.00136	0.00249	CcSEcCtD
Diclofenamide—Tinnitus—Epirubicin—urinary bladder cancer	0.00135	0.00248	CcSEcCtD
Diclofenamide—Headache—Gemcitabine—urinary bladder cancer	0.00135	0.00248	CcSEcCtD
Diclofenamide—Vomiting—Fluorouracil—urinary bladder cancer	0.00135	0.00247	CcSEcCtD
Diclofenamide—Rash—Fluorouracil—urinary bladder cancer	0.00134	0.00245	CcSEcCtD
Diclofenamide—Headache—Fluorouracil—urinary bladder cancer	0.00133	0.00244	CcSEcCtD
Diclofenamide—Asthenia—Etoposide—urinary bladder cancer	0.00132	0.00242	CcSEcCtD
Diclofenamide—Pruritus—Etoposide—urinary bladder cancer	0.0013	0.00239	CcSEcCtD
Diclofenamide—Nausea—Gemcitabine—urinary bladder cancer	0.00128	0.00235	CcSEcCtD
Diclofenamide—Vomiting—Cisplatin—urinary bladder cancer	0.00128	0.00234	CcSEcCtD
Diclofenamide—Rash—Cisplatin—urinary bladder cancer	0.00127	0.00232	CcSEcCtD
Diclofenamide—Nausea—Fluorouracil—urinary bladder cancer	0.00126	0.00231	CcSEcCtD
Diclofenamide—Tinnitus—Doxorubicin—urinary bladder cancer	0.00125	0.0023	CcSEcCtD
Diclofenamide—Tension—Epirubicin—urinary bladder cancer	0.00124	0.00228	CcSEcCtD
Diclofenamide—Nervousness—Epirubicin—urinary bladder cancer	0.00123	0.00225	CcSEcCtD
Diclofenamide—Dizziness—Etoposide—urinary bladder cancer	0.00122	0.00223	CcSEcCtD
Diclofenamide—Leukopenia—Methotrexate—urinary bladder cancer	0.00121	0.00222	CcSEcCtD
Diclofenamide—Nausea—Cisplatin—urinary bladder cancer	0.00119	0.00219	CcSEcCtD
Diclofenamide—Vomiting—Etoposide—urinary bladder cancer	0.00117	0.00215	CcSEcCtD
Diclofenamide—Rash—Etoposide—urinary bladder cancer	0.00116	0.00213	CcSEcCtD
Diclofenamide—Headache—Etoposide—urinary bladder cancer	0.00115	0.00212	CcSEcCtD
Diclofenamide—Tension—Doxorubicin—urinary bladder cancer	0.00115	0.00211	CcSEcCtD
Diclofenamide—Nervousness—Doxorubicin—urinary bladder cancer	0.00114	0.00208	CcSEcCtD
Diclofenamide—Leukopenia—Epirubicin—urinary bladder cancer	0.00113	0.00208	CcSEcCtD
Diclofenamide—Confusional state—Methotrexate—urinary bladder cancer	0.00111	0.00204	CcSEcCtD
Diclofenamide—Nausea—Etoposide—urinary bladder cancer	0.00109	0.00201	CcSEcCtD
Diclofenamide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00108	0.00198	CcSEcCtD
Diclofenamide—Anorexia—Methotrexate—urinary bladder cancer	0.00105	0.00193	CcSEcCtD
Diclofenamide—Leukopenia—Doxorubicin—urinary bladder cancer	0.00105	0.00192	CcSEcCtD
Diclofenamide—Confusional state—Epirubicin—urinary bladder cancer	0.00104	0.00191	CcSEcCtD
Diclofenamide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00101	0.00185	CcSEcCtD
Diclofenamide—Paraesthesia—Methotrexate—urinary bladder cancer	0.00099	0.00182	CcSEcCtD
Diclofenamide—Anorexia—Epirubicin—urinary bladder cancer	0.000983	0.0018	CcSEcCtD
Diclofenamide—Somnolence—Methotrexate—urinary bladder cancer	0.00098	0.0018	CcSEcCtD
Diclofenamide—Dyspepsia—Methotrexate—urinary bladder cancer	0.00097	0.00178	CcSEcCtD
Diclofenamide—Confusional state—Doxorubicin—urinary bladder cancer	0.000962	0.00177	CcSEcCtD
Diclofenamide—Decreased appetite—Methotrexate—urinary bladder cancer	0.000958	0.00176	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000952	0.00175	CcSEcCtD
Diclofenamide—Fatigue—Methotrexate—urinary bladder cancer	0.00095	0.00174	CcSEcCtD
Diclofenamide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000935	0.00171	CcSEcCtD
Diclofenamide—Paraesthesia—Epirubicin—urinary bladder cancer	0.000926	0.0017	CcSEcCtD
Diclofenamide—Somnolence—Epirubicin—urinary bladder cancer	0.000917	0.00168	CcSEcCtD
Diclofenamide—Anorexia—Doxorubicin—urinary bladder cancer	0.00091	0.00167	CcSEcCtD
Diclofenamide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000908	0.00167	CcSEcCtD
Diclofenamide—Dyspepsia—Epirubicin—urinary bladder cancer	0.000908	0.00167	CcSEcCtD
Diclofenamide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000897	0.00165	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000891	0.00163	CcSEcCtD
Diclofenamide—Fatigue—Epirubicin—urinary bladder cancer	0.000889	0.00163	CcSEcCtD
Diclofenamide—Constipation—Epirubicin—urinary bladder cancer	0.000882	0.00162	CcSEcCtD
Diclofenamide—Body temperature increased—Methotrexate—urinary bladder cancer	0.000871	0.0016	CcSEcCtD
Diclofenamide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000857	0.00157	CcSEcCtD
Diclofenamide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00085	0.00156	CcSEcCtD
Diclofenamide—Somnolence—Doxorubicin—urinary bladder cancer	0.000849	0.00156	CcSEcCtD
Diclofenamide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00084	0.00154	CcSEcCtD
Diclofenamide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00083	0.00152	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000824	0.00151	CcSEcCtD
Diclofenamide—Fatigue—Doxorubicin—urinary bladder cancer	0.000823	0.00151	CcSEcCtD
Diclofenamide—Constipation—Doxorubicin—urinary bladder cancer	0.000816	0.0015	CcSEcCtD
Diclofenamide—Body temperature increased—Epirubicin—urinary bladder cancer	0.000816	0.0015	CcSEcCtD
Diclofenamide—Asthenia—Methotrexate—urinary bladder cancer	0.000791	0.00145	CcSEcCtD
Diclofenamide—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000787	0.00144	CcSEcCtD
Diclofenamide—Pruritus—Methotrexate—urinary bladder cancer	0.00078	0.00143	CcSEcCtD
Diclofenamide—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000755	0.00138	CcSEcCtD
Diclofenamide—Asthenia—Epirubicin—urinary bladder cancer	0.00074	0.00136	CcSEcCtD
Diclofenamide—Pruritus—Epirubicin—urinary bladder cancer	0.00073	0.00134	CcSEcCtD
Diclofenamide—Dizziness—Methotrexate—urinary bladder cancer	0.000729	0.00134	CcSEcCtD
Diclofenamide—Vomiting—Methotrexate—urinary bladder cancer	0.000701	0.00129	CcSEcCtD
Diclofenamide—Rash—Methotrexate—urinary bladder cancer	0.000695	0.00128	CcSEcCtD
Diclofenamide—Headache—Methotrexate—urinary bladder cancer	0.000691	0.00127	CcSEcCtD
Diclofenamide—Asthenia—Doxorubicin—urinary bladder cancer	0.000685	0.00126	CcSEcCtD
Diclofenamide—Dizziness—Epirubicin—urinary bladder cancer	0.000682	0.00125	CcSEcCtD
Diclofenamide—Pruritus—Doxorubicin—urinary bladder cancer	0.000675	0.00124	CcSEcCtD
Diclofenamide—Vomiting—Epirubicin—urinary bladder cancer	0.000656	0.0012	CcSEcCtD
Diclofenamide—Nausea—Methotrexate—urinary bladder cancer	0.000655	0.0012	CcSEcCtD
Diclofenamide—Rash—Epirubicin—urinary bladder cancer	0.00065	0.00119	CcSEcCtD
Diclofenamide—Headache—Epirubicin—urinary bladder cancer	0.000646	0.00119	CcSEcCtD
Diclofenamide—Dizziness—Doxorubicin—urinary bladder cancer	0.000631	0.00116	CcSEcCtD
Diclofenamide—Nausea—Epirubicin—urinary bladder cancer	0.000613	0.00112	CcSEcCtD
Diclofenamide—Vomiting—Doxorubicin—urinary bladder cancer	0.000607	0.00111	CcSEcCtD
Diclofenamide—Rash—Doxorubicin—urinary bladder cancer	0.000602	0.0011	CcSEcCtD
Diclofenamide—Headache—Doxorubicin—urinary bladder cancer	0.000598	0.0011	CcSEcCtD
Diclofenamide—Nausea—Doxorubicin—urinary bladder cancer	0.000567	0.00104	CcSEcCtD
Diclofenamide—CA9—Metabolism—NAT1—urinary bladder cancer	0.000515	0.00266	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—NAT2—urinary bladder cancer	0.000506	0.00261	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—NAT2—urinary bladder cancer	0.000506	0.00261	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CYP4B1—urinary bladder cancer	0.000503	0.0026	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—SLC19A1—urinary bladder cancer	0.000496	0.00256	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—TYMP—urinary bladder cancer	0.000484	0.0025	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PRSS3—urinary bladder cancer	0.000483	0.00249	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CYP4B1—urinary bladder cancer	0.000482	0.00249	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—SLC19A1—urinary bladder cancer	0.000475	0.00245	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—NAT2—urinary bladder cancer	0.000473	0.00244	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—NAT2—urinary bladder cancer	0.000473	0.00244	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—UGT2B7—urinary bladder cancer	0.000471	0.00243	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PRSS3—urinary bladder cancer	0.000463	0.00239	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—ATM—urinary bladder cancer	0.000458	0.00237	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—CDK4—urinary bladder cancer	0.000456	0.00236	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—SLC19A1—urinary bladder cancer	0.000455	0.00235	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—RRM2—urinary bladder cancer	0.000448	0.00232	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PRSS3—urinary bladder cancer	0.000444	0.00229	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—NAT2—urinary bladder cancer	0.000438	0.00226	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—RRM2—urinary bladder cancer	0.000437	0.00226	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—RRM2—urinary bladder cancer	0.000437	0.00226	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYP4B1—urinary bladder cancer	0.000424	0.00219	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000421	0.00218	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000415	0.00215	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—ENO2—urinary bladder cancer	0.000415	0.00215	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—HPGDS—urinary bladder cancer	0.000415	0.00215	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—RRM2—urinary bladder cancer	0.000408	0.00211	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—RRM2—urinary bladder cancer	0.000408	0.00211	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—HPGDS—urinary bladder cancer	0.000405	0.00209	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—ENO2—urinary bladder cancer	0.000405	0.00209	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—ENO2—urinary bladder cancer	0.000405	0.00209	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—HPGDS—urinary bladder cancer	0.000405	0.00209	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—GSTT1—urinary bladder cancer	0.000403	0.00208	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—SLC19A1—urinary bladder cancer	0.0004	0.00207	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—CREBBP—urinary bladder cancer	0.000398	0.00206	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—RB1—urinary bladder cancer	0.000397	0.00205	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GSTT1—urinary bladder cancer	0.000392	0.00203	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GSTT1—urinary bladder cancer	0.000392	0.00203	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PRSS3—urinary bladder cancer	0.00039	0.00202	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—TYMP—urinary bladder cancer	0.000386	0.00199	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—RRM2—urinary bladder cancer	0.000378	0.00195	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ENO2—urinary bladder cancer	0.000378	0.00195	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—HPGDS—urinary bladder cancer	0.000378	0.00195	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—HPGDS—urinary bladder cancer	0.000378	0.00195	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ENO2—urinary bladder cancer	0.000378	0.00195	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—TYMP—urinary bladder cancer	0.00037	0.00191	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GSTT1—urinary bladder cancer	0.000366	0.00189	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GSTT1—urinary bladder cancer	0.000366	0.00189	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—TYMP—urinary bladder cancer	0.000355	0.00183	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—ENO2—urinary bladder cancer	0.00035	0.00181	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—HPGDS—urinary bladder cancer	0.00035	0.00181	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—NAT2—urinary bladder cancer	0.000349	0.0018	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—CDKN2A—urinary bladder cancer	0.000349	0.0018	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GSTT1—urinary bladder cancer	0.000339	0.00175	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.000337	0.00174	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—NQO1—urinary bladder cancer	0.000335	0.00173	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—NAT2—urinary bladder cancer	0.000335	0.00173	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000326	0.00169	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—NQO1—urinary bladder cancer	0.000326	0.00168	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—NQO1—urinary bladder cancer	0.000326	0.00168	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—NAT2—urinary bladder cancer	0.000321	0.00166	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—CXCL8—urinary bladder cancer	0.000316	0.00163	CbGpPWpGaD
Diclofenamide—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000315	0.00163	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—TYMP—urinary bladder cancer	0.000312	0.00161	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—NQO1—urinary bladder cancer	0.000305	0.00157	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—NQO1—urinary bladder cancer	0.000305	0.00157	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—RRM2—urinary bladder cancer	0.000301	0.00156	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—RRM2—urinary bladder cancer	0.000289	0.00149	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—CDKN1A—urinary bladder cancer	0.000285	0.00147	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—NQO1—urinary bladder cancer	0.000282	0.00146	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NAT2—urinary bladder cancer	0.000282	0.00146	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—GSTP1—urinary bladder cancer	0.000279	0.00144	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ENO2—urinary bladder cancer	0.000279	0.00144	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—HPGDS—urinary bladder cancer	0.000279	0.00144	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—RRM2—urinary bladder cancer	0.000277	0.00143	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GSTP1—urinary bladder cancer	0.000272	0.00141	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GSTP1—urinary bladder cancer	0.000272	0.00141	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—EP300—urinary bladder cancer	0.000271	0.0014	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTT1—urinary bladder cancer	0.000271	0.0014	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—HPGDS—urinary bladder cancer	0.000268	0.00138	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ENO2—urinary bladder cancer	0.000268	0.00138	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—TYMS—urinary bladder cancer	0.00026	0.00134	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTT1—urinary bladder cancer	0.00026	0.00134	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—GSTM1—urinary bladder cancer	0.000257	0.00133	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—NCOR1—urinary bladder cancer	0.000257	0.00133	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ENO2—urinary bladder cancer	0.000257	0.00133	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—HPGDS—urinary bladder cancer	0.000257	0.00133	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GSTP1—urinary bladder cancer	0.000254	0.00131	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GSTP1—urinary bladder cancer	0.000254	0.00131	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—TYMS—urinary bladder cancer	0.000253	0.00131	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—TYMS—urinary bladder cancer	0.000253	0.00131	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GSTM1—urinary bladder cancer	0.00025	0.00129	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GSTM1—urinary bladder cancer	0.00025	0.00129	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—NCOR1—urinary bladder cancer	0.00025	0.00129	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—NCOR1—urinary bladder cancer	0.00025	0.00129	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTT1—urinary bladder cancer	0.000249	0.00129	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—GPX1—urinary bladder cancer	0.000246	0.00127	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—RRM2—urinary bladder cancer	0.000244	0.00126	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000243	0.00126	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—ERCC2—urinary bladder cancer	0.000241	0.00125	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GPX1—urinary bladder cancer	0.000239	0.00124	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GPX1—urinary bladder cancer	0.000239	0.00124	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—TYMS—urinary bladder cancer	0.000236	0.00122	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—TYMS—urinary bladder cancer	0.000236	0.00122	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GSTP1—urinary bladder cancer	0.000235	0.00122	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—ERCC2—urinary bladder cancer	0.000235	0.00121	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—ERCC2—urinary bladder cancer	0.000235	0.00121	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GSTM1—urinary bladder cancer	0.000233	0.00121	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—NCOR1—urinary bladder cancer	0.000233	0.00121	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—NCOR1—urinary bladder cancer	0.000233	0.00121	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GSTM1—urinary bladder cancer	0.000233	0.00121	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—MTHFR—urinary bladder cancer	0.000227	0.00117	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.000226	0.00117	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—HPGDS—urinary bladder cancer	0.000226	0.00117	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ENO2—urinary bladder cancer	0.000226	0.00117	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—NQO1—urinary bladder cancer	0.000225	0.00116	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GPX1—urinary bladder cancer	0.000223	0.00115	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GPX1—urinary bladder cancer	0.000223	0.00115	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000223	0.00115	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—MTHFR—urinary bladder cancer	0.000221	0.00114	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—MTHFR—urinary bladder cancer	0.000221	0.00114	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ERCC2—urinary bladder cancer	0.000219	0.00113	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ERCC2—urinary bladder cancer	0.000219	0.00113	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—TYMS—urinary bladder cancer	0.000219	0.00113	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTT1—urinary bladder cancer	0.000219	0.00113	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—NCOR1—urinary bladder cancer	0.000216	0.00112	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GSTM1—urinary bladder cancer	0.000216	0.00112	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—NQO1—urinary bladder cancer	0.000216	0.00111	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.000208	0.00107	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GPX1—urinary bladder cancer	0.000207	0.00107	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—NQO1—urinary bladder cancer	0.000207	0.00107	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—MTHFR—urinary bladder cancer	0.000206	0.00107	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—MTHFR—urinary bladder cancer	0.000206	0.00107	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000205	0.00106	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—ERCC2—urinary bladder cancer	0.000203	0.00105	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—TP53—urinary bladder cancer	0.000194	0.001	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—MTHFR—urinary bladder cancer	0.000191	0.000987	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTP1—urinary bladder cancer	0.000188	0.000969	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PPARG—urinary bladder cancer	0.000184	0.00095	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NQO1—urinary bladder cancer	0.000182	0.000939	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTP1—urinary bladder cancer	0.00018	0.000929	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PPARG—urinary bladder cancer	0.000179	0.000926	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PPARG—urinary bladder cancer	0.000179	0.000926	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CREBBP—urinary bladder cancer	0.000177	0.000912	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—TYMS—urinary bladder cancer	0.000174	0.000901	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTP1—urinary bladder cancer	0.000172	0.000891	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—NCOR1—urinary bladder cancer	0.000172	0.000891	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTM1—urinary bladder cancer	0.000172	0.000891	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CREBBP—urinary bladder cancer	0.000172	0.000889	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CREBBP—urinary bladder cancer	0.000172	0.000889	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PPARG—urinary bladder cancer	0.000167	0.000864	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PPARG—urinary bladder cancer	0.000167	0.000864	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—TYMS—urinary bladder cancer	0.000167	0.000864	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTM1—urinary bladder cancer	0.000165	0.000854	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—NCOR1—urinary bladder cancer	0.000165	0.000854	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GPX1—urinary bladder cancer	0.000165	0.000853	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ERCC2—urinary bladder cancer	0.000162	0.000837	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CREBBP—urinary bladder cancer	0.000161	0.00083	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CREBBP—urinary bladder cancer	0.000161	0.00083	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—TYMS—urinary bladder cancer	0.00016	0.000828	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—NCOR1—urinary bladder cancer	0.000158	0.000819	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTM1—urinary bladder cancer	0.000158	0.000819	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GPX1—urinary bladder cancer	0.000158	0.000818	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ERCC2—urinary bladder cancer	0.000155	0.000803	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PPARG—urinary bladder cancer	0.000155	0.0008	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—MTHFR—urinary bladder cancer	0.000152	0.000787	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GPX1—urinary bladder cancer	0.000152	0.000784	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTP1—urinary bladder cancer	0.000152	0.000783	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ERCC2—urinary bladder cancer	0.000149	0.00077	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CREBBP—urinary bladder cancer	0.000149	0.000769	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—MTHFR—urinary bladder cancer	0.000146	0.000755	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PTGS2—urinary bladder cancer	0.000145	0.000747	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—TYMS—urinary bladder cancer	0.000141	0.000728	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PTGS2—urinary bladder cancer	0.000141	0.000728	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PTGS2—urinary bladder cancer	0.000141	0.000728	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—MTHFR—urinary bladder cancer	0.00014	0.000724	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NCOR1—urinary bladder cancer	0.000139	0.00072	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTM1—urinary bladder cancer	0.000139	0.00072	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	0.000139	0.000716	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GPX1—urinary bladder cancer	0.000133	0.000689	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PTGS2—urinary bladder cancer	0.000132	0.00068	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PTGS2—urinary bladder cancer	0.000132	0.00068	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	0.000131	0.000679	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NAT1—urinary bladder cancer	0.000131	0.000679	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ERCC2—urinary bladder cancer	0.000131	0.000677	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000129	0.000668	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PTEN—urinary bladder cancer	0.000126	0.000652	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PPARG—urinary bladder cancer	0.000124	0.000638	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—MTHFR—urinary bladder cancer	0.000123	0.000636	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PTEN—urinary bladder cancer	0.000123	0.000635	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PTEN—urinary bladder cancer	0.000123	0.000635	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PTGS2—urinary bladder cancer	0.000122	0.00063	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—EP300—urinary bladder cancer	0.00012	0.000621	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	0.00012	0.000621	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CREBBP—urinary bladder cancer	0.000119	0.000613	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PPARG—urinary bladder cancer	0.000118	0.000612	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—EP300—urinary bladder cancer	0.000117	0.000606	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—EP300—urinary bladder cancer	0.000117	0.000606	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PTEN—urinary bladder cancer	0.000115	0.000593	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PTEN—urinary bladder cancer	0.000115	0.000593	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CREBBP—urinary bladder cancer	0.000114	0.000588	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PPARG—urinary bladder cancer	0.000114	0.000587	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—EP300—urinary bladder cancer	0.000109	0.000565	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—EP300—urinary bladder cancer	0.000109	0.000565	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CREBBP—urinary bladder cancer	0.000109	0.000564	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	0.000108	0.000559	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PTEN—urinary bladder cancer	0.000106	0.000549	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	0.000102	0.000528	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—EP300—urinary bladder cancer	0.000101	0.000524	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PPARG—urinary bladder cancer	9.98e-05	0.000516	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	9.96e-05	0.000515	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PTGS2—urinary bladder cancer	9.72e-05	0.000502	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CREBBP—urinary bladder cancer	9.59e-05	0.000496	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PTGS2—urinary bladder cancer	9.32e-05	0.000481	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PTGS2—urinary bladder cancer	8.93e-05	0.000462	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PTEN—urinary bladder cancer	8.48e-05	0.000438	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PTEN—urinary bladder cancer	8.13e-05	0.00042	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—EP300—urinary bladder cancer	8.08e-05	0.000418	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.99e-05	0.000413	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—TYMP—urinary bladder cancer	7.96e-05	0.000411	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PTGS2—urinary bladder cancer	7.85e-05	0.000406	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PTEN—urinary bladder cancer	7.79e-05	0.000403	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—EP300—urinary bladder cancer	7.75e-05	0.0004	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.65e-05	0.000395	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—EP300—urinary bladder cancer	7.43e-05	0.000384	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NAT2—urinary bladder cancer	7.2e-05	0.000372	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PTEN—urinary bladder cancer	6.85e-05	0.000354	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—EP300—urinary bladder cancer	6.53e-05	0.000337	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—RRM2—urinary bladder cancer	6.22e-05	0.000321	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ENO2—urinary bladder cancer	5.76e-05	0.000297	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	5.76e-05	0.000297	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.72e-05	0.000296	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	5.58e-05	0.000288	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.5e-05	0.000284	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NQO1—urinary bladder cancer	4.64e-05	0.00024	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.5e-05	0.000233	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.93e-05	0.000203	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	3.87e-05	0.0002	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.74e-05	0.000193	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—TYMS—urinary bladder cancer	3.6e-05	0.000186	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	3.56e-05	0.000184	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	3.56e-05	0.000184	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GPX1—urinary bladder cancer	3.41e-05	0.000176	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	3.34e-05	0.000173	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	3.14e-05	0.000162	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PPARG—urinary bladder cancer	2.55e-05	0.000132	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	2.45e-05	0.000126	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2e-05	0.000104	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.75e-05	9.03e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.67e-05	8.61e-05	CbGpPWpGaD
